BioGraph 55

San Francisco, CA · Founded 2014 · Privately Held (backing)

Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. BioGraph 55 is based in San Francisco, CA and was founded in 2014. Its last known valuation is $25 million. It has raised $20.1 million.

Last price · $/share
—
Implied valuation
$25.0M
Total raised
$20.1M
Last round
—

Who backs BioGraph 55?

6 investors
InvestorType
University of CaliforniaOther
Pfizer VenturesOther
Red Tree Venture CapitalVenture capital
Panacea VentureVenture capital
Los Angeles—
Pathway Bioventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioGraph 55 investors

6 investors are on record for BioGraph 55, including University of California, Pfizer Ventures, Red Tree Venture Capital and Panacea Venture.

Free account
More of BioGraph 55 with a free account
  • ·Watch BioGraph 55: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like BioGraph 55. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View